ArticleVaccine: X2024

Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study.

Anan Bzami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.